InvestorsHub Logo
Followers 6
Posts 172
Boards Moderated 0
Alias Born 03/25/2012

Re: namtae post# 207293

Thursday, 06/23/2016 8:21:10 PM

Thursday, June 23, 2016 8:21:10 PM

Post# of 409537
Nam - Do you just ignore the revenue generated by our current generics? That revenue would have made the company cash flow positive without R&D costs for Eli 200. So are you saying that R&D is a nightmare? How on earth can you come close to saying this is a nightmare? This is what responsible growing multi billion dollar pharmas do - and Nasrat is doing it quite well! Explain why the facts are a nightmare. Max
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News